Royal Bank of Canada’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,921
| Closed | -$3K | – | 7313 |
|
|
2023
Q1 | $3K | Sell |
1,921
-3,325
| -63% | -$5.19K | ﹤0.01% | 6343 |
|
|
2022
Q4 | $8K | Buy |
5,246
+4,828
| +1,155% | +$7.36K | ﹤0.01% | 6159 |
|
|
2022
Q3 | $1K | Buy |
418
+258
| +161% | +$617 | ﹤0.01% | 6854 |
|
|
2022
Q2 | $0 | Sell |
160
-1,663
| -91% | – | ﹤0.01% | 7352 |
|
|
2022
Q1 | $13K | Buy |
+1,823
| New | +$13K | ﹤0.01% | 6369 |
|
|
2021
Q4 | – | Sell |
-79
| Closed | -$1K | – | 7374 |
|
|
2021
Q3 | $1K | Buy |
+79
| New | +$1K | ﹤0.01% | 7012 |
|
|
2021
Q2 | – | Sell |
-6,124
| Closed | -$61K | – | 7143 |
|
|
2021
Q1 | $61K | Buy |
+6,124
| New | +$61K | ﹤0.01% | 5284 |
|